The efficacy and safety of two doses of strontium ranelate versus placebo administered orally for 3 years in the treatment of knee osteoarthritis: a prospective multicentre, international, double-blind, placebo-controlled study.
Phase of Trial: Phase III
Latest Information Update: 05 Nov 2013
At a glance
- Drugs Strontium ranelate (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- 30 Apr 2013 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 17 Apr 2010 New trial record